Literature DB >> 32207769

Coronavirus Disease 2019 and Influenza 2019-2020.

Edward Livingston, Karen Bucher, Andrew Rekito.   

Abstract

Entities:  

Year:  2020        PMID： 32207769     DOI： 10.1001/jama.2020.2633

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  23 in total

1.  Seasonal Influenza Activity During the SARS-CoV-2 Outbreak in Japan.

Authors:  Haruka Sakamoto; Masahiro Ishikane; Peter Ueda
Journal:  JAMA       Date:  2020-05-19       Impact factor: 56.272

2.  An investigation of the Sustainability of Village Savings and Loans Associations (VSLAs) amidst Covid-19 and its impact on household income levels: lessons from Malawi, Sub-Saharan Africa.

Authors:  George N Chidimbah Munthali; Xuelian Wu; Mastano Nambiro Woleson Dzimbiri; Amon Zolo; John K B Mushani; Lazarus Obed Livingstone Banda
Journal:  BMC Public Health       Date:  2022-05-31       Impact factor: 4.135

3.  Management strategies for children with COVID-19: ESPR practical recommendations.

Authors:  Maria Raissaki; Susan C Shelmerdine; Maria Beatrice Damasio; Seema Toso; Ola Kvist; Jovan Lovrenski; Franz Wolfgang Hirsch; Süreyya Burcu Görkem; Anne Paterson; Owen J Arthurs; Andrea Rossi; Joost van Schuppen; Philippe Petit; Maria I Argyropoulou; Amaka C Offiah; Karen Rosendahl; Pablo Caro-Domínguez
Journal:  Pediatr Radiol       Date:  2020-07-03

4.  The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 studies from 9 countries.

Authors:  Michael C Grant; Luke Geoghegan; Marc Arbyn; Zakaria Mohammed; Luke McGuinness; Emily L Clarke; Ryckie G Wade
Journal:  PLoS One       Date:  2020-06-23       Impact factor: 3.240

Review 5.  Potential therapeutic targets and promising drugs for combating SARS-CoV-2.

Authors:  Hong Zhou; Yan Fang; Tao Xu; Wei-Jian Ni; Ai-Zong Shen; Xiao-Ming Meng
Journal:  Br J Pharmacol       Date:  2020-06-05       Impact factor: 8.739

6.  Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.

Authors:  H Keipp Talbot; Emily T Martin; Manjusha Gaglani; Donald B Middleton; Shekhar Ghamande; Fernanda P Silveira; Kempapura Murthy; Richard K Zimmerman; Christopher H Trabue; Samantha M Olson; Joshua G Petrie; Jill M Ferdinands; Manish M Patel; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2021-12-16       Impact factor: 9.079

7.  Different T cell related immunological profiles in COVID-19 patients compared to healthy controls.

Authors:  Armin Mahmoud Salehi Khesht; Vahid Karpisheh; Balsam Qubais Saeed; Angelina Olegovna Zekiy; Lis M Yapanto; Mohsen Nabi Afjadi; Mohsen Aksoun; Maryam Nasr Esfahani; Fatemeh Aghakhani; Mahsa Movahed; Navneet Joshi; Kazem Abbaszadeh-Goudarzi; Shahin Hallaj; Majid Ahmadi; Sanam Dolati; Ata Mahmoodpoor; Vida Hashemi; Farhad Jadidi-Niaragh
Journal:  Int Immunopharmacol       Date:  2021-05-28       Impact factor: 5.714

Review 8.  Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.

Authors:  Amir Emami; Fatemeh Javanmardi; Neda Pirbonyeh; Ali Akbari
Journal:  Arch Acad Emerg Med       Date:  2020-03-24

9.  Exploring Personal Protection During High-Risk PCI in a COVID-19 Patient: Impella CP Mechanical Support During ULMCA Bifurcation Stenting.

Authors:  Luca Bettari; Gaetano Pero; Cristian Maiandi; Antonio Messina; Matteo Saccocci; Marco Cirillo; Giovanni Troise; Elena Conti; Claudio Cuccia; Diego Maffeo
Journal:  JACC Case Rep       Date:  2020-04-10

10.  Disappearance of summer influenza in the Okinawa prefecture during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

Authors:  Satoko Sunagawa; Yoshikazu Iha; Takeshi Kinjo; Katsunori Nakamura; Jiro Fujita
Journal:  Respir Investig       Date:  2020-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.